Get started
Author

Lu Yang

A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens
2024 · Nicole M. Mattson, Anthony K. N. Chan, et al. · Nature Structural & Molecular Biology · 23
PDF
Assessment of Background Parenchymal Enhancement at Dynamic Contrast-enhanced MRI in Predicting Breast Cancer Recurrence Risk
2024 · Dooman Arefan, Margarita L. Zuley, et al. · Radiology · 17
PDF
Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size
2024 · Lin Lin, Jingrong Zhao, et al. · Neuron · 16
PDF
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1
2024 · Leisi Zhang, Honghai Zhang, et al. · Advanced Science · 10
Editor’s Note: Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia
2025 · Yiman Liu, Qinglan Li, et al. · Cancer Discovery
PDF
Abstract 6234: Targeting integrin alpha V beta 5 heterodimer stability using a novel small molecular inhibitor for tumor suppression
2023 · Nicole Mattson, Kazuya Miyashita, et al. · Cancer Research
Abstract 5755: TP63 fusions drive enhancer rewiring, lymphomagenesis, and dependence on EZH2
2023 · Gongwei Wu, Noriaki Yoshida, et al. · Cancer Research
Abstract 2967: ACTR5 maintains hepatocellular carcinoma via H3K9 epigenetic silencing of CDKN2A
2022 · Xiaobao Xu, Lu Yang, et al. · Cancer Research
Abstract 2188: The N6-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer
2022 · Brandon Tan, Wei Liu, et al. · Cancer Research
Abstract 2920: Targeting integrin alpha V beta 5 heterodimer stability using a novel small molecular inhibitor for tumor suppression
2022 · Nicole Mattson, Kazuya Miyashita, et al. · Cancer Research
Works count: 10
Citation count: 66
H-index: 4
I10-index: 4
Year
Topic
Type